Migratory polyarthritis in familial hypercholesterolemia (type IIa hyperlipoproteinemia). 2010

Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
Department of Medicine, Midnapore Medical College, Paschim Medinipur, West Bengal, India. docparthapc@yahoo.co.in

Metabolic disorders are often encountered in clinical practice. Some of these diseases are associated with dermatological and musculoskeletal manifestations. Familial hypercholesterolemia is a disorder of lipoprotein metabolism characterized by elevated cholesterol, low-density lipoprotein cholesterol, xanthomas and early onset atherosclerosis. Tendinitis and arthritis have been rarely reported in patients with familial hypercholesterolemia. Here is presented a case of a young girl with migratory polyarthritis, who was diagnosed as probable homozygote familial hypercholesterolemia with hypercholesterolemic arthritis. A proper knowledge of cutaneous manifestations helps to identify patients at risk, establish the underlying diagnosis, and start early and effective therapy.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides

Related Publications

Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
June 1968, Arthritis and rheumatism,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
June 1984, Harefuah,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
January 1968, University of Michigan Medical Center journal,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
November 1977, Pediatriia,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
July 1978, Vnitrni lekarstvi,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
January 2015, The Pan African medical journal,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
July 1984, Archives of neurology,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
April 1984, No to shinkei = Brain and nerve,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
February 1976, Annals of clinical research,
Partha Pratim Chakraborty, and Sagnik Mukhopadhyay, and Arun Achar, and Mallika Pal, and Prabodh Chandra Mondal
April 1995, Metabolism: clinical and experimental,
Copied contents to your clipboard!